Literature DB >> 31970413

Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults.

Erin C Hanlon1, Rachel Leproult1, Kara L Stuhr2, Elizabeth M Doncheck2, Cecilia J Hillard2, Eve Van Cauter1.   

Abstract

CONTEXT: The endocannabinoid (eCB) system partly controls hedonic eating, a major cause of obesity. While some studies suggested an overactivation of the eCB system in obesity, peripheral levels of eCBs across the 24-hour cycle have not been characterized in obese individuals despite the fact that in lean adults, levels of the eCB 2-arachidonoylglycerol (2-AG) vary across the day.
OBJECTIVE: We sought to examine 24-hour profiles of serum concentrations of 2-AG in healthy obese and nonobese adults, under well-controlled laboratory conditions. We also simultaneously assessed 24-hour profiles of 2-oleoylglycerol (2-OG), leptin, and cortisol in each participant.
DESIGN: With fixed light-dark and sleep-wake cycles, blood sampling was performed over an entire 24-hour period, including identical meals at 0900, 1400, and 1900. PARTICIPANTS: Twelve obese (8 women, mean body mass index [BMI]: 39.1 kg/m2) and 15 nonobese (6 women; mean BMI: 23.6 kg/m2) healthy adults were studied.
RESULTS: We observed a 24-hour variation of 2-AG levels in obese individuals but, relative to nonobese adults, the amplitude was dampened and the timings of the nadir and peak were delayed by 4 to 5 hours. The profile of 2-OG was similarly misaligned. In contrast, when expressed relative to the 24-hour mean level, the 24-hour rhythm of cortisol and leptin were similar in obese and nonobese participants.
CONCLUSIONS: Obesity appears to be associated with a dampening and delay of the 24-hour variation of eCB activity relative to the central circadian signal as well as to the daily leptin rhythm. This misalignment may play a role in the pathophysiology of obesity. © Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  circadian rhythms; cortisol; endocannabinoids; hedonic eating; leptin

Mesh:

Substances:

Year:  2020        PMID: 31970413      PMCID: PMC7015463          DOI: 10.1210/clinem/dgaa028

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  62 in total

1.  A longitudinal study on the effect of shift work on weight gain in male Japanese workers.

Authors:  Yasushi Suwazono; Mirei Dochi; Kouichi Sakata; Yasushi Okubo; Mitsuhiro Oishi; Kumihiko Tanaka; Etsuko Kobayashi; Teruhiko Kido; Koji Nogawa
Journal:  Obesity (Silver Spring)       Date:  2008-06-05       Impact factor: 5.002

2.  Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).

Authors:  Erin C Hanlon
Journal:  Psychoneuroendocrinology       Date:  2019-10-04       Impact factor: 4.905

3.  Activation of the peripheral endocannabinoid system in human obesity.

Authors:  Stefan Engeli; Jana Böhnke; Mareike Feldpausch; Kerstin Gorzelniak; Jürgen Janke; Sándor Bátkai; Pál Pacher; Judy Harvey-White; Friedrich C Luft; Arya M Sharma; Jens Jordan
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

4.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

Review 5.  Endocannabinoids and obesity.

Authors:  Guoxun Chen; Zhen Pang
Journal:  Vitam Horm       Date:  2013       Impact factor: 3.421

6.  Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

Authors:  W A Devane; L Hanus; A Breuer; R G Pertwee; L A Stevenson; G Griffin; D Gibson; A Mandelbaum; A Etinger; R Mechoulam
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

7.  Hyperphagia in pre-fed rats following oral delta9-THC.

Authors:  C M Williams; P J Rogers; T C Kirkham
Journal:  Physiol Behav       Date:  1998-11-15

8.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Authors:  T Sugiura; S Kondo; A Sukagawa; S Nakane; A Shinoda; K Itoh; A Yamashita; K Waku
Journal:  Biochem Biophys Res Commun       Date:  1995-10-04       Impact factor: 3.575

9.  Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

Authors:  Luc F Van Gaal; André J Scheen; Aila M Rissanen; Stephan Rössner; Corinne Hanotin; Olivier Ziegler
Journal:  Eur Heart J       Date:  2008-04-15       Impact factor: 29.983

10.  Rimonabant: From RIO to Ban.

Authors:  Amir H Sam; Victoria Salem; Mohammad A Ghatei
Journal:  J Obes       Date:  2011-07-06
View more
  3 in total

1.  Influence of diet on acute endocannabinoidome mediator levels post exercise in active women, a crossover randomized study.

Authors:  Fabiola Forteza; Isabelle Bourdeau-Julien; Guillaume Q Nguyen; Fredy Alexander Guevara Agudelo; Gabrielle Rochefort; Lydiane Parent; Volatiana Rakotoarivelo; Perrine Feutry; Cyril Martin; Julie Perron; Benoît Lamarche; Nicolas Flamand; Alain Veilleux; François Billaut; Vincenzo Di Marzo; Frédéric Raymond
Journal:  Sci Rep       Date:  2022-05-20       Impact factor: 4.996

2.  The association of dietary patterns with endocannabinoids levels in overweight and obese women.

Authors:  Neda Lotfi Yagin; Samaneh Hajjarzadeh; Soghra Aliasgharzadeh; Fereshteh Aliasgari; Reza Mahdavi
Journal:  Lipids Health Dis       Date:  2020-07-06       Impact factor: 3.876

Review 3.  Sleep and circadian rhythms: pillars of health-a Keystone Symposia report.

Authors:  Jennifer Cable; Eva Schernhammer; Erin C Hanlon; Céline Vetter; Jonathan Cedernaes; Nour Makarem; Hassan S Dashti; Ari Shechter; Christopher Depner; Ashley Ingiosi; Christine Blume; Xiao Tan; Elie Gottlieb; Christian Benedict; Eve Van Cauter; Marie-Pierre St-Onge
Journal:  Ann N Y Acad Sci       Date:  2021-08-02       Impact factor: 6.499

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.